Dialysis patients may benefit from common supplements, study finds

NCT ID NCT07303088

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether taking L-carnitine or Coenzyme Q10 supplements could lower oxidative stress (a type of cell damage) in adults with end-stage kidney disease who are on regular hemodialysis. Fifty-two participants took one of the supplements or a placebo for 12 weeks, followed by a 12-week washout period. Researchers measured blood markers of oxidative stress before, after treatment, and after the washout to see if the supplements helped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE (ESRD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Social security fund polyclinic

    Sfax, Sfax Ville, 3080, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.